Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03573596
Title Persistence of MR3 in Chronic Myeloid Leukemia (CML) After a 2nd Stop of TKI Treatment (DASTOP2)
Acronym DASTOP2
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Amsterdam UMC, location VUmc
Indications
Therapies
Age Groups: adult | senior
Covered Countries SWE | NOR | NLD | FRA | FIN | DNK | DEU


No variant requirements are available.